Sirolimus Market Size, Share & Trends Analysis Report, By Application (Organ Transplantation and Autoimmune Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.), By Dosage (Injections, Tablets, and Others) and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1004973 | Industries : Healthcare | Published On :January 2024 | Page Count : 232

Sirolimus Market Size, Share & Trends Analysis Report, By Application (Organ Transplantation and Autoimmune Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.), By Dosage (Injections, Tablets, and Others) and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Sirolimus market estimated at USD 295 million in 2022 and which expected, at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2030. Key players in the Sirolimus market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Sirolimus market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

SIROLIMUS MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Growing Incidence of Organ Transplantations
The increasing prevalence of organ transplantations, including kidney and liver transplants, is a significant driver for the sirolimus market. Sirolimus is commonly used as an immunosuppressant to prevent organ rejection after transplantation. The rising demand for transplant procedures globally contributes to the growth of the sirolimus market.
Side Effects and Safety Concerns
Despite its efficacy in preventing organ rejection, sirolimus is associated with various side effects, including mouth ulcers, high blood pressure, and an increased risk of infections. Safety concerns and adverse reactions may limit its usage in some patients, affecting the widespread adoption of sirolimus and posing a restraint to the market's growth. Continuous monitoring and management of side effects are crucial considerations in the use of sirolimus.

How are Segments Performing in the Global Sirolimus Market?

Sirolimus Application Segment Breakdown
According to Analytical Market Research, the Sirolimus market by Application is segmented into Organ Transplantation and Autoimmune Diseases.
Sirolimus Distribution Channel Segment Breakdown
According to Analytical Market Research, based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
Sirolimus Dosage Segment Breakdown
According to Analytical Market Research, based on Dosage the market is segmented into Injections, Tablets, and Others.
Sirolimus Geographic Exploration
According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the rise in the automotive industry in the region. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: Sirolimus

The significant players rapidly evolve with new strategies to attain a competitive edge and capture significant market share.
• For Instance, in March 2022, The US FDA has approved Nobelpharma's Hyftor (sirolimus topical gel) for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and patients over the age of six..

Noticeable Players Functioning in The Global Sirolimus Market Include:

• Accord Healthcare Actiza Pharmaceutical Private Limited
• Delphis Pharmaceutical
• Apotex Inc
• Biocon Concept Medical Intas Pharmaceuticals Ltd
• Concord Biotech
• Livzon
• Amneal Pharmaceuticals LLC.
• Pfizer Inc.
• Zydus Cadila
• Dr. Reddy's Laboratories Ltd.

KEY BREAKDOWN: Sirolimus Market

By Application:
• Organ Transplantation
• Autoimmune Diseases
By Dosage:
• Injections
• Tablets
• Others
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o U.K.
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa

1. Research Methodology
1.1. Global Sirolimus Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Sirolimus Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Dosages
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Sirolimus Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Sirolimus Market Outlook: Application
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Application, 2023 – 2030
4.3.2.1. Organ Transplantation
4.3.2.2. Autoimmune Diseases
4.4. Global Sirolimus Market Outlook: Dosage
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Dosage, 2023 – 2030
4.4.2.1. Injections
4.4.2.2. Tablets
4.4.2.3. Others
4.5. Global Sirolimus Market Outlook: Distribution Channel
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
4.5.3. Hospital Pharmacies
4.5.4. Retail Pharmacies
4.5.5. Online Pharmacies
5. Global Sirolimus Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Sirolimus Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Application
6.3.3. By Dosage
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
6.5.1. Organ Transplantation
6.5.2. Autoimmune Diseases
6.6. Market Size (US$ Mn) and Forecast By Dosage, 2023 – 2030
6.6.1. Injections
6.6.2. Tablets
6.6.3. Others
6.7. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
6.7.1. Hospital Pharmacies
6.7.2. Retail Pharmacies
6.7.3. Online Pharmacies
7. Europe Sirolimus Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Application
7.3.3. By Dosage
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
7.5.1. Organ Transplantation
7.5.2. Autoimmune Diseases
7.6. Market Size (US$ Mn) and Forecast By Dosage, 2023 – 2030
7.6.1. Injections
7.6.2. Tablets
7.6.3. Others
7.7. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
7.7.1. Hospital Pharmacies
7.7.2. Retail Pharmacies
7.7.3. Online Pharmacies
8. Asia Pacific Sirolimus Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Application
8.3.3. By Dosage
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
8.5.1. Inner Ear Application
8.5.2. Middle Ear Application
8.5.3. Outer Ear Application
8.6. Market Size (US$ Mn) and Forecast By Dosage, 2023 – 2030
8.6.1. Injections
8.6.2. Tablets
8.6.3. Others
8.7. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
8.7.1. Hospital Pharmacies
8.7.2. Retail Pharmacies
8.7.3. Online Pharmacies
9. Latin America Sirolimus Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Application
9.3.3. By Dosage
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
9.5.1. Organ Transplantation
9.5.2. Autoimmune Diseases
9.6. Market Size (US$ Mn) and Forecast By Dosage, 2023 – 2030
9.6.1. Injections
9.6.2. Tablets
9.6.3. Others
9.7. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
9.7.1. Hospital Pharmacies
9.7.2. Retail Pharmacies
9.7.3. Online Pharmacies
10. Middle East & Africa Sirolimus Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Application
10.3.3. By Dosage
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
10.5.1. Organ Transplantation
10.5.2. Autoimmune Diseases
10.6. Market Size (US$ Mn) and Forecast By Dosage, 2023 – 2030
10.6.1. Injections
10.6.2. Tablets
10.6.3. Others
10.7. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. Online Pharmacies
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Dr. Reddy's Laboratories Ltd.
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Accord Healthcare Actiza Pharmaceutical Private Limited
11.3.3. Delphis Pharmaceutical
11.3.4. Apotex Inc
11.3.5. Biocon Concept Medical Intas Pharmaceuticals Ltd
11.3.6. Concord Biotech
11.3.7. Livzon
11.3.8. Amneal Pharmaceuticals LLC.
11.3.9. Pfizer Inc.
11.3.10. Zydus Cadila